Polo-like kinases play essential roles in cell cycle control and mitosis. In contrast to other members of this kinase family, PLK3 has been reported to be activated upon cellular stress including DNA damage, hypoxia and osmotic stress. Here we knocked out PLK3 in human non-transformed RPE cells using CRISPR/Cas9-mediated gene editing. Surprisingly, we find that loss of PLK3 does not impair stabilization of HIF1α after hypoxia, phosphorylation of the c-Jun after osmotic stress and dynamics of DNA damage response after exposure to ionizing radiation. Similarly, RNAi-mediated depletion of PLK3 did not impair stress response in human transformed cell lines. Exposure of cells to various forms of stress also did not affect kinase activity of purified EGFP-PLK3. We conclude that PLK3 is largely dispensable for stress response in human cells. Using mass spectrometry, we identify protein phosphatase 6 as a new interacting partner of PLK3. Polo box domain of PLK3 mediates the interaction with the PP6 complex. Finally, we find that PLK3 is phosphorylated at Thr219 in the T-loop and that PP6 constantly dephosphorylates this residue. However, in contrast to PLK1, phosphorylation of Thr219 does not upregulate enzymatic activity of PLK3, suggesting that activation of both kinases is regulated by distinct mechanisms.

Cancer Cell Biology Institute of Molecular Genetics of the Czech Academy of Sciences CZ14220 Prague Czech Republic

Zobrazit více v PubMed

Zitouni S., Nabais C., Jana S.C., Guerrero A., Bettencourt-Dias M. Polo-like kinases: Structural variations lead to multiple functions. Nat. Rev. Mol. Cell Biol. 2014;15:433–452. doi: 10.1038/nrm3819. PubMed DOI

Elia A.E.H., Rellos P., Haire L.F., Chao J.W., Ivins F.J., Hoepker K., Mohammad D., Cantley L.C., Smerdon S.J., Yaffe M.B. The Molecular Basis for Phosphodependent Substrate Targeting and Regulation of Plks by the Polo-Box Domain. Cell. 2003;115:83–95. doi: 10.1016/S0092-8674(03)00725-6. PubMed DOI

Lens S.M.A., Voest E.E., Medema R.H. Shared and separate functions of polo-like kinases and aurora kinases in cancer. Nat. Rev. Cancer. 2010;10:825–841. doi: 10.1038/nrc2964. PubMed DOI

Petronczki M., Lénárt P., Peters J.-M. Polo on the Rise-from Mitotic Entry to Cytokinesis with Plk1. Dev. Cell. 2008;14:646–659. doi: 10.1016/j.devcel.2008.04.014. PubMed DOI

Habedanck R., Stierhof Y.-D., Wilkinson C.J., Nigg E.A. The Polo kinase Plk4 functions in centriole duplication. Nat. Cell Biol. 2005;7:1140–1146. doi: 10.1038/ncb1320. PubMed DOI

De Cárcer G., Escobar B., Higuero A.M., García L., Ansón A., Pérez G., Mollejo M., Manning G., Meléndez B., Abad-Rodríguez J., et al. Plk5, a Polo Box Domain-Only Protein with Specific Roles in Neuron Differentiation and Glioblastoma Suppression. Mol. Cell. Biol. 2011;31:1225–1239. doi: 10.1128/MCB.00607-10. PubMed DOI PMC

Holtrich U., Wolf G., Yuan J., Bereiter-Hahn J., Karn T., Weiler M., Kauselmann G., Rehli M., Andreesen R., Kaufmann M., et al. Adhesion induced expression of the serine/threonine kinase Fnk in human macrophages. Oncogene. 2000;19:4832–4839. doi: 10.1038/sj.onc.1203845. PubMed DOI

Ma S., Liu M.-A., Yuan Y.-L.O., Erikson R.L. The serum-inducible protein kinase Snk is a G1 phase polo-like kinase that is inhibited by the calcium- and integrin-binding protein CIB. Mol. Cancer Res. 2003;1:376–384. PubMed

Zimmerman W.C., Erikson R.L. Polo-like kinase 3 is required for entry into S phase. Proc. Natl. Acad. Sci. USA. 2007;104:1847–1852. doi: 10.1073/pnas.0610856104. PubMed DOI PMC

Bahassi E.L.M., Hennigan R.F., Myer D.L., Stambrook P.J. Cdc25C phosphorylation on serine 191 by Plk3 promotes its nuclear translocation. Oncogene. 2004;23:2658–2663. doi: 10.1038/sj.onc.1207425. PubMed DOI

Myer D.L., Robbins S.B., Yin M., Boivin G.P., Liu Y., Greis K.D., Bahassi E.M., Stambrook P.J. Absence of polo-like kinase 3 in mice stabilizes Cdc25A after DNA damage but is not sufficient to produce tumors. Mutat. Res. 2011;714:1–10. doi: 10.1016/j.mrfmmm.2011.02.006. PubMed DOI PMC

Bahassi E.M., Conn C.W., Myer D.L., Hennigan R.F., McGowan C.H., Sanchez Y., Stambrook P.J. Mammalian Polo-like kinase 3 (Plk3) is a multifunctional protein involved in stress response pathways. Oncogene. 2002;21:6633–6640. doi: 10.1038/sj.onc.1205850. PubMed DOI

Bahassi E.M., Myer D.L., McKenney R.J., Hennigan R.F., Stambrook P.J. Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediates its full activation by ATM and a downstream checkpoint in response to DNA damage. Mutat. Res. 2006;596:166–176. doi: 10.1016/j.mrfmmm.2005.12.002. PubMed DOI

Xie S., Wu H., Wang Q., Cogswell J.P., Husain I., Conn C., Stambrook P., Jhanwar-Uniyal M., Dai W. Plk3 Functionally Links DNA Damage to Cell Cycle Arrest and Apoptosis at Least in Part via the p53 Pathway. J. Biol. Chem. 2001;276:43305–43312. doi: 10.1074/jbc.M106050200. PubMed DOI

Barton O., Naumann S.C., Diemer-Biehs R., Künzel J., Steinlage M., Conrad S., Makharashvili N., Wang J., Feng L., Lopez B.S., et al. Polo-like kinase 3 regulates CtIP during DNA double-strand break repair in G1. J. Cell Biol. 2014;206:877–894. doi: 10.1083/jcb.201401146. PubMed DOI PMC

Wang L., Gao J., Dai W., Lu L. Activation of Polo-like Kinase 3 by Hypoxic Stresses. J. Biol. Chem. 2008;283:25928–25935. doi: 10.1074/jbc.M801326200. PubMed DOI PMC

Xu D., Yao Y., Lu L., Costa M., Dai W. Plk3 Functions as an Essential Component of the Hypoxia Regulatory Pathway by Direct Phosphorylation of HIF-1α. J. Biol. Chem. 2010;285:38944–38950. doi: 10.1074/jbc.M110.160325. PubMed DOI PMC

Yang Y., Bai J., Shen R., Brown S.A.N., Komissarova E., Huang Y., Jiang N., Alberts G.F., Costa M., Lu L., et al. Polo-like Kinase 3 Functions as a Tumor Suppressor and Is a Negative Regulator of Hypoxia-Inducible Factor-1α under Hypoxic Conditions. Cancer Res. 2008;68:4077–4085. doi: 10.1158/0008-5472.CAN-07-6182. PubMed DOI PMC

Wang L., Dai W., Lu L. Osmotic Stress-induced Phosphorylation of H2AX by Polo-like Kinase 3 Affects Cell Cycle Progression in Human Corneal Epithelial Cells. J. Biol. Chem. 2014;289:29827–29835. doi: 10.1074/jbc.M114.597161. PubMed DOI PMC

Wang L., Payton R., Dai W., Lu L. Hyperosmotic Stress-induced ATF-2 Activation through Polo-like Kinase 3 in Human Corneal Epithelial Cells. J. Biol. Chem. 2011;286:1951–1958. doi: 10.1074/jbc.M110.166009. PubMed DOI PMC

Colanzi A., Sutterlin C., Malhotra V. RAF1-activated MEK1 is found on the Golgi apparatus in late prophase and is required for Golgi complex fragmentation in mitosis. J. Cell Biol. 2003;161:27–32. doi: 10.1083/jcb.200208099. PubMed DOI PMC

Xie S., Wang Q., Ruan Q., Liu T., Jhanwar-Uniyal M., Guan K., Dai W. MEK1-induced Golgi dynamics during cell cycle progression is partly mediated by Polo-like kinase-3. Oncogene. 2004;23:3822–3829. doi: 10.1038/sj.onc.1207479. PubMed DOI

Ruan Q., Wang Q., Xie S., Fang Y., Darzynkiewicz Z., Guan K., Jhanwar-Uniyal M., Dai W. Polo-like kinase 3 is Golgi localized and involved in regulating Golgi fragmentation during the cell cycle. Exp. Cell Res. 2004;294:51–59. doi: 10.1016/j.yexcr.2003.10.022. PubMed DOI

Stefansson B., Ohama T., Daugherty A.E., Brautigan D.L. Protein Phosphatase 6 Regulatory Subunits Composed of Ankyrin Repeat Domains. Biochemistry. 2008;47:1442–1451. doi: 10.1021/bi7022877. PubMed DOI

Ohama T. The multiple functions of protein phosphatase 6. Biochimi. Biophys. Acta (BBA) Mol. Cell Res. 2019;1866:74–82. doi: 10.1016/j.bbamcr.2018.07.015. PubMed DOI

Rusin S.F., Schlosser K.A., Adamo M.E., Kettenbach A.N. Quantitative phosphoproteomics reveals new roles for the protein phosphatase PP6 in mitotic cells. Sci. Signal. 2015;8:rs12. doi: 10.1126/scisignal.aab3138. PubMed DOI PMC

Zeng K., Bastos R.N., Barr F.A., Gruneberg U. Protein phosphatase 6 regulates mitotic spindle formation by controlling the T-loop phosphorylation state of Aurora A bound to its activator TPX2. J. Cell Biol. 2010;191:1315–1332. doi: 10.1083/jcb.201008106. PubMed DOI PMC

Mi J., Dziegielewski J., Bolesta E., Brautigan D.L., Larner J.M. Activation of DNA-PK by Ionizing Radiation Is Mediated by Protein Phosphatase 6. PLoS ONE. 2009;4:e4395. doi: 10.1371/journal.pone.0004395. PubMed DOI PMC

Shen Y., Wang Y., Sheng K., Fei X., Guo Q., Larner J., Kong X., Qiu Y., Mi J. Serine/threonine protein phosphatase 6 modulates the radiation sensitivity of glioblastoma. Cell Death Dis. 2011;2:e241. doi: 10.1038/cddis.2011.126. PubMed DOI PMC

Hayashi K., Momoi Y., Tanuma N., Kishimoto A., Ogoh H., Kato H., Suzuki M., Sakamoto Y., Inoue Y., Nomura M., et al. Abrogation of protein phosphatase 6 promotes skin carcinogenesis induced by DMBA. Oncogene. 2015;34:4647–4655. doi: 10.1038/onc.2014.398. PubMed DOI

Hammond D., Zeng K., Espert A., Bastos R.N., Baron R.D., Gruneberg U., Barr F.A. Melanoma-associated mutations in protein phosphatase 6 cause chromosome instability and DNA damage owing to dysregulated Aurora-A. J. Cell Sci. 2013;126:3429–3440. doi: 10.1242/jcs.128397. PubMed DOI

Burdova K., Storchova R., Palek M., Macurek L. WIP1 Promotes Homologous Recombination and Modulates Sensitivity to PARP Inhibitors. Cells. 2019;8:1258. doi: 10.3390/cells8101258. PubMed DOI PMC

Xu X., Stern D.F. NFBD1/KIAA0170 Is a Chromatin-associated Protein Involved in DNA Damage Signaling Pathways. J. Biol. Chem. 2003;278:8795–8803. doi: 10.1074/jbc.M211392200. PubMed DOI

Macůrek L., Lindqvist A., Voets O., Kool J., Vos H.R., Medema R.H. Wip1 phosphatase is associated with chromatin and dephosphorylates γH2AX to promote checkpoint inhibition. Oncogene. 2010;29:2281–2291. doi: 10.1038/onc.2009.501. PubMed DOI

Alberts G., Winkles J. Murine FGF-inducible kinase is rapidly degraded via the nuclear ubiquitin-proteosome system when overexpressed in NIH 3T3 cells. Cell Cycle. 2004;3:678–684. doi: 10.4161/cc.3.5.865. PubMed DOI

Helmke C., Raab M., Rödel F., Matthess Y., Oellerich T., Mandal R., Sanhaji M., Urlaub H., Rödel C., Becker S., et al. Ligand stimulation of CD95 induces activation of Plk3 followed by phosphorylation of caspase-8. Cell Res. 2016;26:914–934. doi: 10.1038/cr.2016.78. PubMed DOI PMC

Jiang N., Wang X., Jhanwar-Uniyal M., Darzynkiewicz Z., Dai W. Polo Box Domain of Plk3 Functions as a Centrosome Localization Signal, Overexpression of Which Causes Mitotic Arrest, Cytokinesis Defects, and Apoptosis. J. Biolo. Chem. 2006;281:10577–10582. doi: 10.1074/jbc.M513156200. PubMed DOI

Wang L., Dai W., Lu L. Stress-induced c-Jun Activation Mediated by Polo-like Kinase 3 in Corneal Epithelial Cells. J. Biol. Chem. 2007;282:32121–32127. doi: 10.1074/jbc.M702791200. PubMed DOI

Ziv Y., Bielopolski D., Galanty Y., Lukas C., Taya Y., Schultz D.C., Lukas J., Bekker-Jensen S., Bartek J., Shiloh Y. Chromatin relaxation in response to DNA double-strand breaks is modulated by a novel ATM- and KAP-1 dependent pathway. Nat. Cell Biol. 2006;8:870–876. doi: 10.1038/ncb1446. PubMed DOI

Kleiblova P., Stolarova L., Krizova K., Lhota F., Hojny J., Zemankova P., Havranek O., Vocka M., Cerna M., Lhotova K., et al. Identification of deleterious germline CHEK2 mutations and their association with breast and ovarian cancer. Int. J. Cancer. 2019;145:1782–1797. doi: 10.1002/ijc.32385. PubMed DOI

Van Vugt M.A.T.M., Smits V.A.J., Klompmaker R., Medema R.H. Inhibition of Polo-like Kinase-1 by DNA Damage Occurs in an ATM- or ATR-dependent Fashion. J. Biol. Chem. 2001;276:41656–41660. doi: 10.1074/jbc.M101831200. PubMed DOI

Kettenbach A.N., Schlosser K.A., Lyons S.P., Nasa I., Gui J., Adamo M.E., Gerber S.A. Global assessment of its network dynamics reveals that the kinase Plk1 inhibits the phosphatase PP6 to promote Aurora A activity. Sci. Signal. 2018;11:eaaq1441. doi: 10.1126/scisignal.aaq1441. PubMed DOI PMC

Macurek L., Lindqvist A., Lim D., Lampson M.A., Klompmaker R., Freire R., Clouin C., Taylor S.S., Yaffe M.B., Medema R.H. Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery. Nature. 2008;455:119–123. doi: 10.1038/nature07185. PubMed DOI

Bruinsma W., Macůrek L., Freire R., Lindqvist A., Medema R.H. Bora and Aurora-A continue to activate Plk1 in mitosis. J. Cell Sci. 2014;127:801–811. doi: 10.1242/jcs.137216. PubMed DOI

Chan E.H.Y., Santamaria A., Silljé H.W., Nigg E.A. Plk1 regulates mitotic Aurora A function through βTrCP-dependent degradation of hBora. Chromosom. Biol. Nucl. 2008;117:457–469. doi: 10.1007/s00412-008-0165-5. PubMed DOI PMC

Swingle M., Ni L., Honkanen R.E. Small-molecule inhibitors of ser/thr protein phosphatases: Specificity, use and common forms of abuse. Methods Mol. Biol. 2007;365:23–38. doi: 10.1385/1-59745-267-X:23. PubMed DOI PMC

Watanabe K., Umeda T., Niwa K., Naguro I., Ichijo H. A PP6-ASK3 Module Coordinates the Bidirectional Cell Volume Regulation under Osmotic Stress. Cell Rep. 2018;22:2809–2817. doi: 10.1016/j.celrep.2018.02.045. PubMed DOI

Bhandari D., Zhang J., Menon S., Lord C., Chen S., Helm J., Thorsen K., Corbett K., Hay J., Ferro-Novick S. Sit4p/PP6 Regulates ER-to-Golgi Traffic by Controlling the Dephosphorylation of COPII Coat Subunits. Mol. Biol. Cell. 2013;24:2727–2738. doi: 10.1091/mbc.e13-02-0114. PubMed DOI PMC

Ohama T., Wang L., Griner E., Brautigan D. Protein Ser/Thr phosphatase-6 is required for maintenance of E-cadherin at adherens junctions. BMC Cell Biol. 2013;14:42. doi: 10.1186/1471-2121-14-42. PubMed DOI PMC

Lin C., Bai S., Du T., Lai Y., Chen X., Peng S., Ma X., Wu W., Guo Z., Huang H. Polo-like kinase 3 is associated with poor prognosis and regulates proliferation and metastasis in prostate cancer. Cancer Manag. Res. 2019;11:1517–1524. doi: 10.2147/CMAR.S176762. PubMed DOI PMC

Babagana M., Kichina J.V., Slabodkin H., Johnson S., Maslov A., Brown L., Attwood K., Nikiforov M.A., Kandel E.S. The role of polo-like kinase 3 in the response of BRAF-mutant cells to targeted anticancer therapies. Mol. Carcinog. 2020;59:5–14. doi: 10.1002/mc.23123. PubMed DOI PMC

Ou B., Sun H., Zhao J., Xu Z., Liu Y., Feng H., Peng Z. Polo-like kinase 3 inhibits glucose metabolism in colorectal cancer by targeting HSP90/STAT3/HK2 signaling. J. Exp. Clin. Cancer Res. CR. 2019;38:426. doi: 10.1186/s13046-019-1418-2. PubMed DOI PMC

CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather than Checkmate